U.S. Pharmaceuticals & Biotech Breakout Stocks

Moderna

Market Cap: US$25.1b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

BioNTech

Market Cap: US$23.3b

Engages in the development and commercialization of immunotherapies in Germany.

Amylyx Pharmaceuticals

Market Cap: US$3.9b

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Eton Pharmaceuticals

Market Cap: US$1.8b

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Maravai LifeSciences Holdings

Market Cap: US$1.5b

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Omeros

Market Cap: US$1.2b

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

Kura Oncology

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Climb Bio

Market Cap: US$998.8m

A clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases.

Candel Therapeutics

Market Cap: US$922.0m

A clinical stage biopharmaceutical company, develops immunotherapies for cancer patients.

4D Molecular Therapeutics

Market Cap: US$813.2m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Achieve Life Sciences

Market Cap: US$773.8m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

Assembly Biosciences

Market Cap: US$654.2m

A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.

OmniAb

Market Cap: US$569.9m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

AVITA Medical

Market Cap: US$304.6m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Acumen Pharmaceuticals

Market Cap: US$198.1m

A clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease.

Acrivon Therapeutics

Market Cap: US$87.8m

A clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.

Apollomics

Market Cap: US$52.5m

A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.

Brainstorm Cell Therapeutics

Market Cap: US$15.6m

A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

International Stem Cell

Market Cap: US$3.9m

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

Enzolytics

Market Cap: US$3.4m

A drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.

Zenith Capital

Market Cap: US$3.2m

A biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs.

CBD of Denver

Market Cap: US$1.1m

Engages in developing and commercializing cannabidiol (CBD) products.

Biomolecular Life Holdings

Market Cap: US$445.9k

Develops and sells wellness and longevity technology products in the United States.

Neutra

Market Cap: US$304.3k

Researches, develops, and provides hemp-derived products in the nutraceutical space in the United States.

Innovation Pharmaceuticals

Market Cap: US$264.4k

A clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective.

Affymax

Market Cap: US$119.2k

Does not have significant operations.

T2 Biosystems

Market Cap: US$14.0k

Engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare.

eFFECTOR Therapeutics

Market Cap: US$3.8k

A biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer.